Treosulfan

Chemical formula: C₆H₁₄O₈S₂  Molecular mass: 278.29 g/mol  PubChem compound: 9882105

Therapeutic indications

Treosulfan is indicated for:

Allogeneic haematopoietic stem cell transplantation (alloHSCT)

Population group: only infants (40 days - 1 year old) , children (1 year - 12 years old) , adolescents (12 years - 18 years old) , adults (18 years old or older)

Treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (alloHSCT) in adult patients and in paediatric patients older than one month with malignant and non-malignant diseases.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Treosulfan is contraindicated in the following cases:

Pregnancy

Pregnancy

Active non-controlled infectious disease

Infectious disease

Fanconi anaemia and other DNA breakage repair disorders

at least one of
Fanconi pancytopenia syndrome
Ataxia-telangiectasia syndrome
Bloom syndrome
Cockayne syndrome
Hutchinson-Gilford syndrome
Rothmund-Thomson syndrome
Werner syndrome
Xeroderma pigmentosum

Severe cardiac impairment

Cardiac failure

Severe renal impairment

at least one of

Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Severe liver impairment

Hepatic failure stage IV

Severe lung impairment

Respiratory failure

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.